ENDRA Life Sciences Inc. (NDRA) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for ENDRA Life Sciences Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -0.51x | -0.61x | -629.86x | -1043.23x | -4411.18x | -2148.29x |
| P/B Ratio | 1.58x | 2.74x | 1119.73x | 1908.36x | 4594.02x | 3513.55x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 1.29x | 5.67x | 3.36x | 5.00x | 7.83x | 8.32x |
| Quick Ratio | 1.29x | 5.67x | 3.36x | 3.45x | 7.00x | 7.72x |
| Leverage | ||||||
| Debt/Equity | 0.22x | 0.23x | 0.07x | 0.08x | 0.07x | 0.11x |
YoY = year-over-year change. Source: FMP..